Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Amy Franks

Concepts (189)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Education, Pharmacy
17
2024
143
8.440
Why?
Schools, Pharmacy
8
2024
54
3.710
Why?
Pharmacy
3
2023
58
2.130
Why?
Writing
4
2024
43
1.840
Why?
Faculty
7
2024
72
1.310
Why?
Professional-Patient Relations
3
2019
47
1.300
Why?
Teaching
4
2024
116
1.120
Why?
Educational Measurement
6
2019
208
1.030
Why?
Students, Pharmacy
4
2021
121
0.910
Why?
Students
3
2024
210
0.890
Why?
Pharmaceutical Services
2
2023
55
0.880
Why?
Fellowships and Scholarships
2
2020
111
0.840
Why?
Learning
2
2024
158
0.840
Why?
Pharmacies
1
2023
61
0.800
Why?
Biomedical Research
1
2024
237
0.780
Why?
Humans
42
2024
49974
0.780
Why?
Patient-Centered Care
2
2019
129
0.710
Why?
Motivational Interviewing
2
2019
32
0.700
Why?
Health Knowledge, Attitudes, Practice
4
2018
488
0.670
Why?
Program Development
2
2018
166
0.610
Why?
Blood Pressure
3
2012
512
0.610
Why?
Probucol
2
2009
3
0.600
Why?
Patient Education as Topic
2
2011
302
0.590
Why?
Achievement
1
2017
39
0.590
Why?
Mass Screening
2
2011
353
0.580
Why?
Perception
1
2017
116
0.560
Why?
Cross-Sectional Studies
7
2020
1557
0.530
Why?
Feedback
1
2016
52
0.530
Why?
Tetrazoles
2
2008
41
0.520
Why?
Antihypertensive Agents
2
2009
117
0.520
Why?
Hypertension
3
2009
533
0.490
Why?
Health Personnel
1
2017
246
0.480
Why?
Research Personnel
2
2024
66
0.440
Why?
Curriculum
5
2019
401
0.420
Why?
Community Health Services
2
2011
101
0.410
Why?
Energy Drinks
1
2012
6
0.410
Why?
Female
17
2024
26472
0.410
Why?
Caffeine
1
2012
67
0.390
Why?
Platelet Aggregation Inhibitors
2
2012
172
0.390
Why?
Faculty, Medical
2
2023
89
0.380
Why?
Coronary Disease
1
2011
131
0.370
Why?
Universities
2
2024
161
0.360
Why?
Cardiovascular Diseases
3
2012
440
0.360
Why?
Male
15
2024
25241
0.360
Why?
Adrenergic beta-Antagonists
1
2009
102
0.330
Why?
Cardiovascular System
1
2009
49
0.320
Why?
Biphenyl Compounds
1
2008
31
0.320
Why?
Angiotensin II Type 1 Receptor Blockers
1
2008
43
0.310
Why?
Benzimidazoles
1
2008
48
0.310
Why?
Thiazolidinediones
1
2007
82
0.280
Why?
Adult
11
2024
13236
0.280
Why?
Coronary Restenosis
1
2005
31
0.260
Why?
Hypoglycemic Agents
1
2007
168
0.260
Why?
Clinical Trials as Topic
4
2009
461
0.240
Why?
Program Evaluation
2
2024
354
0.230
Why?
Smoking
2
2018
511
0.230
Why?
Career Mobility
1
2023
25
0.230
Why?
Policy
1
2023
24
0.230
Why?
Organizational Policy
1
2023
40
0.220
Why?
Academies and Institutes
1
2023
18
0.220
Why?
Communication
2
2022
246
0.220
Why?
Checklist
1
2023
29
0.220
Why?
Angiotensin Receptor Antagonists
1
2003
19
0.220
Why?
Imidazoles
1
2003
119
0.200
Why?
Schools
1
2023
165
0.200
Why?
Angiotensin II
1
2003
157
0.200
Why?
Heart Failure
1
2007
458
0.200
Why?
Itraconazole
3
2008
40
0.190
Why?
Diabetes Mellitus, Type 2
1
2007
477
0.190
Why?
Qualitative Research
1
2023
329
0.190
Why?
Amiodarone
1
2000
22
0.190
Why?
Cannabis
1
2023
145
0.180
Why?
Anti-Arrhythmia Agents
1
2000
79
0.180
Why?
Blood Pressure Monitoring, Ambulatory
2
2012
35
0.180
Why?
Mentors
1
2020
55
0.180
Why?
Heart Arrest
2
2007
149
0.180
Why?
Self Report
1
2020
196
0.160
Why?
Peer Review
1
2018
9
0.160
Why?
Self-Assessment
2
2016
46
0.150
Why?
Pilot Projects
3
2009
699
0.150
Why?
Publishing
1
2018
39
0.150
Why?
Motivation
1
2020
273
0.150
Why?
Risk Factors
4
2011
3613
0.150
Why?
Knowledge
1
2017
28
0.150
Why?
Citrus paradisi
2
2008
10
0.140
Why?
Food-Drug Interactions
2
2008
14
0.140
Why?
Education, Pharmacy, Graduate
1
2016
19
0.140
Why?
Tobacco Products
1
2018
110
0.130
Why?
Pharmacists
3
2023
144
0.130
Why?
Arkansas
3
2023
1977
0.120
Why?
Middle Aged
7
2023
12069
0.120
Why?
Young Adult
3
2018
3958
0.110
Why?
Retrospective Studies
2
2024
6108
0.110
Why?
Antifungal Agents
2
2008
339
0.110
Why?
United States
2
2021
4860
0.110
Why?
Dose-Response Relationship, Drug
2
2008
1376
0.100
Why?
Ticlopidine
1
2012
55
0.100
Why?
Proton Pump Inhibitors
1
2012
84
0.100
Why?
Life Style
1
2011
140
0.090
Why?
Drug Interactions
3
2012
206
0.090
Why?
Atenolol
1
2009
14
0.090
Why?
Cerebrovascular Disorders
1
2009
55
0.090
Why?
Health Behavior
1
2011
254
0.080
Why?
Drug Tolerance
1
2009
60
0.080
Why?
Drug Evaluation, Preclinical
1
2009
144
0.080
Why?
Problem-Based Learning
1
2008
47
0.080
Why?
Beverages
2
2008
68
0.080
Why?
Hirudins
1
2007
16
0.070
Why?
Education, Medical, Undergraduate
1
2008
82
0.070
Why?
Anaphylaxis
1
2007
71
0.070
Why?
Edema
1
2007
67
0.070
Why?
Drugs, Investigational
1
2005
14
0.070
Why?
Students, Medical
1
2008
157
0.070
Why?
Weight Gain
1
2007
240
0.060
Why?
Insulin Resistance
1
2007
264
0.060
Why?
Molecular Structure
1
2005
297
0.060
Why?
Insulin
1
2007
457
0.060
Why?
Risk Assessment
1
2009
1259
0.060
Why?
Anticoagulants
1
2007
250
0.060
Why?
beta-Cyclodextrins
1
2004
16
0.060
Why?
Tachycardia, Ventricular
2
2003
44
0.060
Why?
Antioxidants
1
2005
249
0.060
Why?
Ephedra
1
2003
8
0.060
Why?
Electrocardiography, Ambulatory
1
2003
23
0.060
Why?
Phytotherapy
1
2003
44
0.060
Why?
Plant Preparations
1
2003
38
0.050
Why?
Receptors, Angiotensin
1
2003
13
0.050
Why?
Prescription Fees
1
2003
14
0.050
Why?
Hemostasis
1
2003
55
0.050
Why?
Adolescent
2
2018
6356
0.050
Why?
Practice Guidelines as Topic
2
2007
449
0.050
Why?
Animals
2
2009
13187
0.050
Why?
Aged, 80 and over
1
2009
3129
0.050
Why?
Hepatocytes
1
2003
182
0.050
Why?
Interleukin-6
1
2003
264
0.050
Why?
Ventricular Fibrillation
1
2000
16
0.050
Why?
Attitude of Health Personnel
1
2023
347
0.040
Why?
Aged
2
2012
9310
0.040
Why?
Dietary Supplements
1
2003
443
0.040
Why?
Attitude
1
2019
69
0.040
Why?
Cardiopulmonary Resuscitation
1
2000
133
0.040
Why?
Liver
1
2003
1115
0.040
Why?
Risk
1
2018
320
0.040
Why?
Pregnant Women
1
2018
77
0.040
Why?
Nicotine
1
2018
187
0.040
Why?
Societies, Pharmaceutical
1
2016
12
0.030
Why?
Attitude to Health
1
2018
192
0.030
Why?
Pharmaceutical Solutions
2
2008
8
0.030
Why?
Pandemics
1
2021
559
0.030
Why?
Accreditation
1
2016
60
0.030
Why?
Child
1
2008
6847
0.030
Why?
Area Under Curve
2
2008
182
0.030
Why?
Cross-Over Studies
2
2008
224
0.030
Why?
Time Factors
2
2012
2903
0.030
Why?
Regression Analysis
1
2012
395
0.020
Why?
Acute Coronary Syndrome
1
2012
78
0.020
Why?
Proportional Hazards Models
1
2012
402
0.020
Why?
Pregnancy
1
2018
2607
0.020
Why?
Cohort Studies
1
2012
1422
0.020
Why?
Peer Group
1
2008
53
0.020
Why?
Hospitalization
1
2012
652
0.020
Why?
Cytochrome P-450 CYP3A
1
2008
78
0.020
Why?
Risk Management
1
2007
32
0.020
Why?
Injections, Intravenous
1
2007
140
0.020
Why?
Follow-Up Studies
1
2012
2182
0.020
Why?
Antibodies
1
2007
154
0.020
Why?
Administration, Oral
1
2008
426
0.020
Why?
Renal Insufficiency
1
2007
109
0.020
Why?
Respiratory Insufficiency
1
2007
113
0.020
Why?
Recombinant Proteins
1
2007
486
0.020
Why?
Sex Factors
1
2008
691
0.020
Why?
Clinical Competence
1
2008
393
0.020
Why?
Cyclodextrins
1
2004
17
0.010
Why?
Biological Availability
1
2004
122
0.010
Why?
Ephedrine
1
2003
21
0.010
Why?
Cimetidine
1
2003
7
0.010
Why?
Receptors, Interleukin-6
1
2003
22
0.010
Why?
Diastole
1
2003
69
0.010
Why?
Bradycardia
1
2003
36
0.010
Why?
Systole
1
2003
68
0.010
Why?
Reference Values
1
2003
310
0.010
Why?
Cytochrome P-450 Enzyme System
1
2003
195
0.010
Why?
Patient Compliance
1
2003
230
0.010
Why?
Heart Rate
1
2003
293
0.010
Why?
Body Weight
1
2003
513
0.010
Why?
Enzyme Inhibitors
1
2003
391
0.010
Why?
Body Mass Index
1
2003
652
0.010
Why?
Cells, Cultured
1
2003
1573
0.010
Why?
Treatment Outcome
1
2003
5141
0.010
Why?
Franks's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description